These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32847597)

  • 1. Therapeutic monoclonal antibody targeting of neuronal pentraxin receptor to control metastasis in gastric cancer.
    Kanda M; Shimizu D; Sawaki K; Nakamura S; Umeda S; Miwa T; Tanaka H; Tanaka C; Hayashi M; Iguchi Y; Yamada S; Katsuno M; Kodera Y
    Mol Cancer; 2020 Aug; 19(1):131. PubMed ID: 32847597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Potential of Antibody Targeting Neuronal Pentraxin Receptor in Esophageal Squamous Cell Carcinoma.
    Shinozuka T; Kanda M; Sato Y; Shimizu D; Umeda S; Takami H; Hattori N; Hayashi M; Tanaka C; Kodera Y
    Ann Surg Oncol; 2024 Sep; 31(9):5674-5682. PubMed ID: 38717547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of CHRNB2 signaling with a therapeutic monoclonal antibody attenuates the aggressiveness of gastric cancer cells.
    Kanda M; Shimizu D; Nakamura S; Sawaki K; Umeda S; Miwa T; Tanaka H; Inokawa Y; Hattori N; Hayashi M; Tanaka C; Nakayama G; Iguchi Y; Katsuno M; Kodera Y
    Oncogene; 2021 Sep; 40(36):5495-5504. PubMed ID: 34331011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic antibody targeting natriuretic peptide receptor 1 inhibits gastric cancer growth via BCL-2-mediated intrinsic apoptosis.
    Sasahara M; Kanda M; Tanaka C; Shimizu D; Umeda S; Takami H; Inokawa Y; Hattori N; Hayashi M; Nakayama G; Kodera Y
    Int J Cancer; 2024 Apr; 154(7):1272-1284. PubMed ID: 38151776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncostatin M receptor, positively regulated by SP1, promotes gastric cancer growth and metastasis upon treatment with Oncostatin M.
    Yu Z; Li Z; Wang C; Pan T; Chang X; Wang X; Zhou Q; Wu X; Li J; Zhang J; Liu B; Zhu Z; Su L
    Gastric Cancer; 2019 Sep; 22(5):955-966. PubMed ID: 30778797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthrax toxin receptor 1/tumor endothelial marker 8 promotes gastric cancer progression through activation of the PI3K/AKT/mTOR signaling pathway.
    Cai C; Dang W; Liu S; Huang L; Li Y; Li G; Yan S; Jiang C; Song X; Hu Y; Gu J
    Cancer Sci; 2020 Apr; 111(4):1132-1145. PubMed ID: 31977138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway.
    Li J; Ye D; Shen P; Liu X; Zhou P; Zhu G; Xu Y; Fu Y; Li X; Sun J; Xu J; Zhang Q
    J Exp Clin Cancer Res; 2020 Oct; 39(1):212. PubMed ID: 33032635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Neuronal Pentraxin-2 Pathway Is an Unrecognized Target in Human Neuroblastoma, Which Also Offers Prognostic Value in Patients.
    Bartolini A; Di Paolo D; Noghero A; Murgia D; Sementa AR; Cilli M; Pasqualini R; Arap W; Bussolino F; Ponzoni M; Pastorino F; Marchiò S
    Cancer Res; 2015 Oct; 75(20):4265-71. PubMed ID: 26294210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy.
    Chen JF; Wu P; Xia R; Yang J; Huo XY; Gu DY; Tang CJ; De W; Yang F
    Mol Cancer; 2018 Jan; 17(1):6. PubMed ID: 29329543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through β-catenin/Erk/Akt signaling in gastric cancer.
    Geng B; Pan J; Zhao T; Ji J; Zhang C; Che Y; Yang J; Shi H; Li J; Zhou H; Mu X; Xu C; Wang C; Xu Y; Liu Z; Wen H; You Q
    J Exp Clin Cancer Res; 2018 Aug; 37(1):208. PubMed ID: 30165890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
    Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
    Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.
    Ye J; Huang J; Xu J; Huang Q; Wang J; Zhong W; Lin X; Li Y; Lin X
    BMC Cancer; 2017 Sep; 17(1):626. PubMed ID: 28874138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of TRPV1 ion channels in the suppression of gastric cancer development.
    Gao N; Yang F; Chen S; Wan H; Zhao X; Dong H
    J Exp Clin Cancer Res; 2020 Oct; 39(1):206. PubMed ID: 33008449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer.
    Yoshida K; Tsujimoto H; Matsumura K; Kinoshita M; Takahata R; Matsumoto Y; Hiraki S; Ono S; Seki S; Yamamoto J; Hase K
    Cancer Med; 2015 Sep; 4(9):1322-33. PubMed ID: 26077800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis.
    Chen JJ; Ren YL; Shu CJ; Zhang Y; Chen MJ; Xu J; Li J; Li AP; Chen DY; He JD; Shu YQ; Zhou JW
    J Exp Clin Cancer Res; 2020 Jun; 39(1):118. PubMed ID: 32576271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-203 suppresses invasion of gastric cancer cells by targeting ERK1/2/Slug/ E-cadherin signaling.
    Gao P; Wang S; Jing F; Zhan J; Wang Y
    Cancer Biomark; 2017; 19(1):11-20. PubMed ID: 28269747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. m
    Xie JW; Huang XB; Chen QY; Ma YB; Zhao YJ; Liu LC; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Zheng CH; Huang CM; Li P
    Mol Cancer; 2020 Jul; 19(1):114. PubMed ID: 32650804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XB130 promotes proliferation and invasion of gastric cancer cells.
    Shi M; Zheng D; Sun L; Wang L; Lin L; Wu Y; Zhou M; Liao W; Liao Y; Zuo Q; Liao W
    J Transl Med; 2014 Jan; 12():1. PubMed ID: 24387290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulated hsa_circRNA_100269 inhibits the growth and metastasis of gastric cancer through inactivating PI3K/Akt axis.
    Wang Z; Liu C
    PLoS One; 2021; 16(4):e0250603. PubMed ID: 33901239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of SYT8 For the Detection, Prediction, and Treatment of Peritoneal Metastasis From Gastric Cancer.
    Kanda M; Shimizu D; Tanaka H; Tanaka C; Kobayashi D; Hayashi M; Iwata N; Niwa Y; Yamada S; Fujii T; Sugimoto H; Murotani K; Fujiwara M; Kodera Y
    Ann Surg; 2018 Mar; 267(3):495-503. PubMed ID: 28026832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.